| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.2 |